All News

Crowe’s research honored

Vanderbilt’s James Crowe Jr., MD, was among those to receive 2023 Advocacy Awards from Research!America at the biomedical research advocacy organization’s annual awards program in Washington, D.C.

New executive director of Vanderbilt Health and Wellness Lori Rolando, MD, MPH, left, with Mary Yarbrough, MD, MPH, who had served as executive director of the program since 1994.

Rolando transitions to lead Health and Wellness

Scientists resurrect a ‘dead’ antibody to study protein

Vanderbilt was part of a multi-center team that resurrected a “dead antibody” to reveal the mysteries of cytochrome c, a versatile protein that is an essential part of the cell’s energy-generating capacity, and of life itself.

Cardiovascular research pioneer Inagami mourned

Tadashi Inagami, PhD, DSc, Vanderbilt University Professor of Biochemistry, emeritus, who helped characterize the biochemical basis for hypertension, heart failure and vascular disease, died in Pittsburgh, Pennsylvania, March 13 after a brief illness. He was 92.

Research by Mingjian Shi, PhD, left, Jonathan Mosley, MD, PhD, Kerry Schaffer, MD, MSCI, and colleagues found that polygenic risk score does not improve prediction of aggressive prostate cancer.

Study evaluates polygenic risk score for prostate cancer risk prediction

A Vanderbilt study found that prostate cancer polygenic risk score has limited utility for enhancing prostate cancer screening.

Normal Pressure Hydrocephalus Protocol Team improves lives of hard-to-diagnose patients

“The NPH Protocol exemplifies multiple disciplines working together to improve the lives of patients and their caregivers.”

1 80 81 82 83 84 117